Article

Prediction of Tamoxifen Benefit in Premenopausal Breast Cancer Patients Evaluated by Three Methods for Determination of Hormone Receptor Status

2023-10-02

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Tamoxifen remains an important adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Thus, determination of hormone receptors is important. Here, we compare cytosol-based methods, immunohistochemistry (IHC), and gene expression (GEX) analysis for determining hormone receptor status in premenopausal breast cancer patients from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 808254c6-1c95-5ab3-b965-797aa301632b
DOI: 10.21203/rs.3.rs-3395413/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of Tamoxifen Benefit in Premenopausal Breast Cancer Patients Evaluated by Three Methods for Determination of Hormone Receptor StatusDOI 10.21203/rs.3.rs-3395413/v1Read

Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer - data from the randomized SBII:2 trialSemantic proximity Read

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read

Determination of Hormone Receptors, Human Epidermal Growth Factor Receptor 2 and Ki67 Status in Invasive Breast Carcinoma: A Concordance Study between Immunohistochemistry, Fluorescence in Situ Hybridization, and GeneXpert® Breast Cancer STRAT4 AssaySemantic proximity Read

Menopausal status-dependent alterations in the transcript levels of genes encoding ERα, ERβ, PR and HER2 in breast tumors with different receptor statusSemantic proximity Read

[Temporary dependency of steroid-receptor prognostic value in breast cancer].Semantic proximity Read

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read

Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.Semantic proximity Read

Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.Semantic proximity Read

Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trialSemantic proximity Read

Immunohistochemical evaluation of hormone receptors with predictive value in mammary carcinomas.Semantic proximity Read

Menopausal status does not predict Oncotype DX recurrence score.Semantic proximity Read